Tocqueville Asset Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Sell
265,000
-45,000
-15% -$272K 0.02% 349
2026
Q1
$1.91M Buy
310,000
+10,000
+3% +$83K 0.03% 296
2025
Q4
$3.13M Hold
300,000
0.05% 253
2025
Q3
$2.7M Buy
+300,000
New +$2.63M 0.04% 275

Other funds holding RXST

Tocqueville Asset Management's RXST Position: Q2 2026 in Review

Tocqueville Asset Management reduced its RxSight (RXST) stake by 15% in Q2 2026, selling an estimated $272K and leaving 265,000 shares worth $1.28M. The position accounts for 0.02% of the portfolio, ranked #349.

Tocqueville Asset Management first reported a position in RXST in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.13M in Q4 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Tocqueville Asset Management held 265,000 shares of RxSight worth $1.28M as of Q2 2026.
  • Tocqueville Asset Management sold 45,000 RxSight shares in Q2 2026, an estimated $272K.
  • RxSight made up 0.02% of Tocqueville Asset Management's portfolio in Q2 2026, its #349 holding.
  • Tocqueville Asset Management first reported a position in RxSight in Q3 2025 and has held it in 4 quarters since.
  • Tocqueville Asset Management's RxSight position peaked at $3.13M in Q4 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.